Supplemental material
Renal Failure
Volume 45, 2023 - Issue 1
Open access
2,033
Views
0
CrossRef citations to date
0
Altmetric
Clinical Study
Ginsenoside Rg1 treatment alleviates renal fibrosis by inhibiting the NOX4–MAPK pathway in T2DM mice
Pengmin Jia Department of Pharmacology, School of Basic Medical Sciences, Key Laboratory of Anti-inflammatory and Immunopharmacology, Ministry of Education, Anhui Medical University, Hefei, ChinaView further author information
, Qifeng Shia Department of Pharmacology, School of Basic Medical Sciences, Key Laboratory of Anti-inflammatory and Immunopharmacology, Ministry of Education, Anhui Medical University, Hefei, ChinaView further author information
, Yan Liua Department of Pharmacology, School of Basic Medical Sciences, Key Laboratory of Anti-inflammatory and Immunopharmacology, Ministry of Education, Anhui Medical University, Hefei, ChinaView further author information
, Min Hana Department of Pharmacology, School of Basic Medical Sciences, Key Laboratory of Anti-inflammatory and Immunopharmacology, Ministry of Education, Anhui Medical University, Hefei, ChinaView further author information
, Yong Sub Department of Pharmacy, The First Affiliated Hospital of Anhui Medical University, Hefei, ChinaView further author information
, Ran Suna Department of Pharmacology, School of Basic Medical Sciences, Key Laboratory of Anti-inflammatory and Immunopharmacology, Ministry of Education, Anhui Medical University, Hefei, ChinaView further author information
, Huimin Zhoua Department of Pharmacology, School of Basic Medical Sciences, Key Laboratory of Anti-inflammatory and Immunopharmacology, Ministry of Education, Anhui Medical University, Hefei, ChinaView further author information
, Weizu Lia Department of Pharmacology, School of Basic Medical Sciences, Key Laboratory of Anti-inflammatory and Immunopharmacology, Ministry of Education, Anhui Medical University, Hefei, ChinaCorrespondence[email protected]
View further author information
& View further author information
Weiping Lia Department of Pharmacology, School of Basic Medical Sciences, Key Laboratory of Anti-inflammatory and Immunopharmacology, Ministry of Education, Anhui Medical University, Hefei, ChinaCorrespondence[email protected]
View further author information
show allView further author information
Article: 2197075
|
Received 16 Jan 2023, Accepted 26 Mar 2023, Published online: 05 Apr 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.